Home › Funds › LUMINUS MANAGEMENT LLC › MIST
LUMINUS MANAGEMENT LLC position in MIST
MILESTONE PHARMACEUTICALS IN · Health Care
LUMINUS MANAGEMENT LLC reported holding 275,000 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$238K, representing 0.15% of its reported portfolio and ranking #27 among its reported holdings. LUMINUS MANAGEMENT LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How LUMINUS MANAGEMENT LLC's MIST position evolved
LUMINUS MANAGEMENT LLC first disclosed a stake in MIST in Q3 2026 at 275,000 shares (US$238K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 275.00K | $238.07K | New |
About MIST and 13F data
MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 26 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$8.2M), Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$2.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIST
- Propel Bio Management, LLC 9.45M sh · $8.18M · Q3 2026
- Pavaki Capital Management LLC 9.34M sh · $8.08M · Q3 2026
- Simplify Asset Management Inc. 3.35M sh · $2.90M · Q3 2026
- Kalehua Capital Management LLC 1.65M sh · $1.43M · Q3 2026
- Lion Point Capital, LP 820.00K sh · $709.87K · Q3 2026
- Boxer Capital Management, LLC 666.67K sh · $577.13K · Q3 2026
More on LUMINUS MANAGEMENT LLC
FAQ
How long has LUMINUS MANAGEMENT LLC held MIST?
LUMINUS MANAGEMENT LLC has disclosed MIST holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is LUMINUS MANAGEMENT LLC's current position in MIST?
As of Q3 2026, LUMINUS MANAGEMENT LLC holds 275.00K shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $238.07K, representing 0.15% of its reported portfolio and ranking #27.
Has LUMINUS MANAGEMENT LLC been buying or selling MIST?
In the latest 13F filing (Q3 2026), LUMINUS MANAGEMENT LLC newly opened its position in MIST.
Which other funds hold MIST?
Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Simplify Asset Management Inc., among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.